These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6384352)

  • 1. [Treatment of non-specific menometrorrhagia with naftazone].
    Tadjerouni A; de Muylder JA; Flici O; Vekemans M; Soumenkoff G; Derouaux G; Hubinont PO
    J Gynecol Obstet Biol Reprod (Paris); 1984; 13(4):459-62. PubMed ID: 6384352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the efficacy of a venotonic capillary protector in the treatment of metrorrhagia due to IUD or micropill contraception].
    Monteil-seurin J; Bernard-fernier MF; Martinaggi P; Demarez JP; Cauquil J; Lafont A
    Contracept Fertil Sex (Paris); 1985 May; 13(5):721-5. PubMed ID: 12267101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of epsilon aminocaproic acid in abnormal hemorrhage using intrauterine contraceptive devices].
    Rueda González R
    Rev Colomb Obstet Ginecol; 1969; 20(4):273-8. PubMed ID: 5356119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of uterine bleeding by PGs or their synthesis inhibitors.
    Toppozada M; El-Attar A; El-Ayyat MA; Khamis Y
    Adv Prostaglandin Thromboxane Res; 1980; 8():1459-63. PubMed ID: 6769315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenosem therapy for bleeding coincident with the use of intrauterine contraceptive devices: a double blind study.
    Horne HW; Scott JM
    Fertil Steril; 1970 Mar; 21(3):230-3. PubMed ID: 4907971
    [No Abstract]   [Full Text] [Related]  

  • 6. Uterine bleeding in rhesus monkeys after intrauterine contraceptive device insertion: effect of long-acting antihistaminic drugs.
    Kar AB; Chandra H
    Indian J Exp Biol; 1969 Apr; 7(2):118. PubMed ID: 4389670
    [No Abstract]   [Full Text] [Related]  

  • 7. [A case of intolerance to a contraceptive intrauterine device].
    Konieczny A
    Wiad Lek; 1983 Dec; 36(23):1995-8. PubMed ID: 6675310
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevention of hemorrhage in prostatic surgery. Apropos of the study of the hemostatic activity in prostatectomy of a new molecule: beta-naphthoquinone monosemicarbazone (Naftazone)].
    Charles O; Coolsaet B
    Ann Urol (Paris); 1972 Sep; 6(3):209-12. PubMed ID: 4562066
    [No Abstract]   [Full Text] [Related]  

  • 9. [Indomethacin in the therapy of hemorrhage complicating intrauterine contraception].
    Jánys M; Nesit V
    Cesk Gynekol; 1979 May; 44(4):287-9. PubMed ID: 445610
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of oxytocics in the control of hemorrhages after the insertion of intrauterine devices].
    Marques Mde M; Rodrigues W; Arkader J
    Hospital (Rio J); 1970 Jul; 78(1):177-89. PubMed ID: 5312438
    [No Abstract]   [Full Text] [Related]  

  • 11. Uterine bleeding in amenorrhic rhesus monkeys after intrauterine contraceptive device insertion.
    Kar AB; Chandra H
    Indian J Exp Biol; 1969 Oct; 7(4):263. PubMed ID: 4982637
    [No Abstract]   [Full Text] [Related]  

  • 12. Majzlin intrauterine contraceptive spring. Report of a clinical study.
    Sobrero AJ; Pierotti D
    Obstet Gynecol; 1970 Dec; 36(6):911-8. PubMed ID: 5487744
    [No Abstract]   [Full Text] [Related]  

  • 13. Uterine bleeding in rhesus monkeys after intrauterine contraceptive device insertion: effect of a long-acting progestational steroid, 17 alpha-hydroxyprogesterone caproate.
    Kar AB; Chandra H
    Indian J Exp Biol; 1968 Oct; 6(4):255-6. PubMed ID: 4976299
    [No Abstract]   [Full Text] [Related]  

  • 14. Should endometrial hyperplasia be regarded as a reason for abnormal uterine bleeding in users of the intrauterine contraceptive device?
    Ozalp S; Kabukcuoglu S; Tanir HM
    Eur J Contracept Reprod Health Care; 2003 Mar; 8(1):17-20. PubMed ID: 12725671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary report of a trial of a long acting antihistaminic, buclizine hydrochloride in patients with bleeding after insertion of an intrauterine device.
    Bedi P; Devi PK; Chaudhury RR
    Indian J Med Res; 1968 Jun; 56(6):884. PubMed ID: 4386522
    [No Abstract]   [Full Text] [Related]  

  • 16. [Double blind study with an oral contraceptive (preliminary report)].
    Torres Ramírez A; Arias Huerta J
    Ginecol Obstet Mex; 1970 Jun; 27(164):719-26. PubMed ID: 4931958
    [No Abstract]   [Full Text] [Related]  

  • 17. [Course of pregnancy and the state of the intrauterine fetus after the use of various contraceptive agents].
    Martynshin MIa; Kryzhanovskaia-Kaplun EF; Nikolaeva AM
    Vopr Okhr Materin Det; 1977 Sep; 22(9):60-2. PubMed ID: 919392
    [No Abstract]   [Full Text] [Related]  

  • 18. A double-blind, comparative study of diflunisal and naproxen in the treatment of rheumatoid arthritis.
    Devereaux MD; Douglas WA
    Eur J Rheumatol Inflamm; 1983; 6(3):274-8. PubMed ID: 6391932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some complications of intra-uterine contraceptive devices.
    Henken EM; Solomkin M; Edelstein SW; Horowitz BJ
    Conn Med; 1969 Jul; 33(7):443-6. PubMed ID: 5795836
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy.
    Bourdrez P; Bongers MY; Mol BW
    Fertil Steril; 2004 Jul; 82(1):160-6, quiz 265. PubMed ID: 15237006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.